BrightSpring Health Services, Inc. (BTSG): one to watch?

Not a broken business — a beat-and-raise quarter got sold anyway on valuation worries and thin margins, but it's still pricey and unproven.

👀 WATCH Fundamentals55/100

Fell 21% in 9 trading day(s) — now $57.89

Why BTSG dropped

The drop traces to BrightSpring's Q2 2026 earnings on July 31: it beat estimates and raised full-year guidance, yet the stock still fell hard — a classic "sell the news" after a huge prior run-up, with some follow-on selling tied to an institutional fund trimming its position and continued margin/valuation worries.

Fwd P/E 25.4Op margin 3.4%Rev growth 23.0%Debt/equity 116.0%Analyst upside 36.4%

How this scored 55/100

✅ Passes all 4 hard checks — profitable, cash-generative, and financially survivable.

✅ Makes money Net profit margin 2.5%

✅ Generates cash Free cash flow $1.0B

✅ Not drowning in debt Debt/equity 116.0% (limit 200%)

✅ Can pay its bills Current ratio 1.6 (needs 1+)

Bar length shows how much each metric is worth — a 10-point metric is twice as wide as a 5-point one. Hover any row for what it means.

Profitability Does it actually make money? 5/25

Operating margin 3.4% 1/9

Net profit margin 2.5% 1/8

Return on equity 13.0% 3/8

Growth Is it getting bigger, or dying? 24/25

Revenue growth 23.0% 8/9

Earnings growth 196.6% 8/8

Expected profit change 103.4% 8/8

Value Is it cheap right now? 11/25

Forward P/E 25.4 5/10

PEG ratio unknown 2/8

Analyst target upside 36.4% 4/7

Balance sheet Will it survive? 15/25

Debt / equity 116.0% 5/10

Current ratio 1.6 3/8

Free cash flow $1.0B 7/7

🔒 Read the full AI analysis

Create a free account to unlock the bull case and the risks for BTSG — plus today's other picks.

Analysis generated by SmartStonks's AI from public fundamentals and news, first flagged 2026-08-12. Research only — not financial advice.